Literature DB >> 9415427

Changing patterns of gap junctional intercellular communication and connexin distribution in mouse epidermis and hair follicles during embryonic development.

R Choudhry1, J D Pitts, M B Hodgins.   

Abstract

In the mouse embryo between embryonic days 12 (E12) and 16, regular arrays of epidermal placodes on the mystacial pad develop into whisker follicles. This system was chosen for analysis of gap junctional intercellular communication during differentiation. The patterns of communication were studied by microinjection of the tracers Lucifer yellow-CH (LY-CH) and neurobiotin (NB), while immunofluorescent staining was used to study distribution of connexins 26 and 43. Extensive communication was seen between keratinocytes in developing hair pegs or, in later-stage hair follicles, in the germinative matrix. Coupling between adjacent hair pegs via interfollicular epidermis was not observed. Coupling also became restricted as follicular cells differentiated to form outer root sheath, inner root sheath, and hair shaft. Extensive gap junctional coupling is characteristic of keratinocytes that are rapidly proliferating (as in hair pegs and germinative matrix). Follicular keratinocytes commence differentiation shortly before restriction of gap junctional coupling becomes evident. Dermal mesenchymal cells undergoing different modes of differentiation also exhibit differences in gap junctional coupling, as evidenced by poor transfer of LY-CH between cells in dermal condensations of hair follicles compared with extensive transfer elsewhere in the dermis. LY-CH and NB were not transferred between epidermal or follicular epithelium and mesenchyme, arguing against a direct role for gap junctions permeable to known second messenger molecules or nucleotides in epithelial-mesenchymal interactions in this system. The distribution of connexins 26 and 43 in epidermis and hair follicles changed during differentiation but there was no correlation with changing patterns of dye transfer, indicating an unexpected degree of complexity in the relationship between gap junctional intercellular communication and connexin protein distribution during development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415427     DOI: 10.1002/(SICI)1097-0177(199712)210:4<417::AID-AJA6>3.0.CO;2-J

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  10 in total

Review 1.  Connexin mutations in skin disease and hearing loss.

Authors:  D P Kelsell; W L Di; M J Houseman
Journal:  Am J Hum Genet       Date:  2001-01-25       Impact factor: 11.025

2.  Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response.

Authors:  Ali R Djalilian; David McGaughey; Satyakam Patel; Eun Young Seo; Chenghua Yang; Jun Cheng; Melanija Tomic; Satrajit Sinha; Akemi Ishida-Yamamoto; Julia A Segre
Journal:  J Clin Invest       Date:  2006-04-20       Impact factor: 14.808

3.  Polyamines regulate gap junction communication in connexin 43-expressing cells.

Authors:  L Shore; P McLean; S K Gilmour; M B Hodgins; M E Finbow
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  Differentiation of organotypic epidermis in the presence of skin disease-linked dominant-negative Cx26 mutants and knockdown Cx26.

Authors:  Tamsin Thomas; Qing Shao; Dale W Laird
Journal:  J Membr Biol       Date:  2007-07-20       Impact factor: 1.843

Review 5.  Connexins and pannexins in the integumentary system: the skin and appendages.

Authors:  Chrysovalantou Faniku; Catherine S Wright; Patricia E Martin
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

6.  Connexin 43: Key roles in the skin.

Authors:  Xiao-Fei Zhang; Xiaofeng Cui
Journal:  Biomed Rep       Date:  2017-05-03

7.  GJB2 mutations and degree of hearing loss: a multicenter study.

Authors:  Rikkert L Snoeckx; Patrick L M Huygen; Delphine Feldmann; Sandrine Marlin; Françoise Denoyelle; Jaroslaw Waligora; Malgorzata Mueller-Malesinska; Agneszka Pollak; Rafal Ploski; Alessandra Murgia; Eva Orzan; Pierangela Castorina; Umberto Ambrosetti; Ewa Nowakowska-Szyrwinska; Jerzy Bal; Wojciech Wiszniewski; Andreas R Janecke; Doris Nekahm-Heis; Pavel Seeman; Olga Bendova; Margaret A Kenna; Anna Frangulov; Heidi L Rehm; Mustafa Tekin; Armagan Incesulu; Hans-Henrik M Dahl; Desirée du Sart; Lucy Jenkins; Deirdre Lucas; Maria Bitner-Glindzicz; Karen B Avraham; Zippora Brownstein; Ignacio del Castillo; Felipe Moreno; Nikolaus Blin; Markus Pfister; Istvan Sziklai; Timea Toth; Philip M Kelley; Edward S Cohn; Lionel Van Maldergem; Pascale Hilbert; Anne-Françoise Roux; Michel Mondain; Lies H Hoefsloot; Cor W R J Cremers; Tuija Löppönen; Heikki Löppönen; Agnete Parving; Karen Gronskov; Iris Schrijver; Joseph Roberson; Francesca Gualandi; Alessandro Martini; Geneviéve Lina-Granade; Nathalie Pallares-Ruiz; Céu Correia; Graça Fialho; Kim Cryns; Nele Hilgert; Paul Van de Heyning; Carla J Nishimura; Richard J H Smith; Guy Van Camp
Journal:  Am J Hum Genet       Date:  2005-10-19       Impact factor: 11.025

8.  The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants.

Authors:  Jared M Churko; Stephanie Langlois; Xinyue Pan; Qing Shao; Dale W Laird
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

9.  Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43.

Authors:  Karen Maass; Alexander Ghanem; Jung-Sun Kim; Manuela Saathoff; Stephanie Urschel; Gregor Kirfel; Ruth Grümmer; Markus Kretz; Thorsten Lewalter; Klaus Tiemann; Elke Winterhager; Volker Herzog; Klaus Willecke
Journal:  Mol Biol Cell       Date:  2004-07-28       Impact factor: 4.138

10.  Connexin 26 (GJB2) mutation in an Argentinean patient with keratitis-ichthyosis-deafness (KID) syndrome: a case report.

Authors:  Viviana Karina Dalamón; Paula Buonfiglio; Margarita Larralde; Patricio Craig; Vanesa Lotersztein; Keith Choate; Norma Pallares; Vicente Diamante; Ana Belén Elgoyhen
Journal:  BMC Med Genet       Date:  2016-05-04       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.